Left ventricular remodeling after myocardial infarction: pathophysiology and therapy.
暂无分享,去创建一个
N. Sharpe | M. Sutton | M G Sutton | N Sharpe | M. J. Sutton
[1] Therapy Study Investigators. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure , 1993, The Lancet.
[2] C. Delcayre,et al. Angiotensin AT1 receptor subtype as a cardiac target of aldosterone: role in aldosterone-salt-induced fibrosis. , 1999, Hypertension.
[3] S. Ball. The Sympathetic Nervous System and Converting Enzyme Inhibition , 1989, Journal of cardiovascular pharmacology.
[4] R M Whitlock,et al. Left ventricular end-systolic volume as the major determinant of survival after recovery from myocardial infarction. , 1987, Circulation.
[5] N. Sharpe,et al. TREATMENT OF PATIENTS WITH SYMPTOMLESS LEFT VENTRICULAR DYSFUNCTION AFTER MYOCARDIAL INFARCTION , 1988, The Lancet.
[6] M. Pfeffer,et al. Ventricular Remodeling After Myocardial Infarction: Experimental Observations and Clinical Implications , 1990, Circulation.
[7] B. Chaitman,et al. Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: results of a multicenter prospective randomized, double-blind, placebo-controlled trial. , 1998, Circulation.
[8] S. Kaul,et al. Effects of successful intravenous reperfusion therapy on regional myocardial function and geometry in humans: a tomographic assessment using two-dimensional echocardiography. , 1989, Journal of the American College of Cardiology.
[9] G. Hutchins,et al. Infarct expansion: pathologic analysis of 204 patients with a single myocardial infarct. , 1986, Journal of the American College of Cardiology.
[10] D. Ganten,et al. Selective activation of cardiac angiotensinogen gene expression in post-infarction ventricular remodeling in the rat. , 1993, Journal of molecular and cellular cardiology.
[11] H. White,et al. Long-term prognostic importance of patency of the infarct-related coronary artery after thrombolytic therapy for acute myocardial infarction. , 1994, Circulation.
[12] G. Gamble,et al. Early prevention of left ventricular dysfunction after myocardial infarction with angiotensin-converting-enzyme inhibition , 1991, The Lancet.
[13] H. Nagase. Activation mechanisms of matrix metalloproteinases. , 1997, Biological chemistry.
[15] I. Dixon,et al. Expression of Gqα and PLC-β in Scar and Border Tissue in Heart Failure Due to Myocardial Infarction , 1998 .
[16] K. Teo,et al. Primary stenting versus balloon angioplasty in occluded coronary arteries: the Total Occlusion Study of Canada (TOSCA). , 1999, Circulation.
[17] G Olivetti,et al. Side-to-side slippage of myocytes participates in ventricular wall remodeling acutely after myocardial infarction in rats. , 1990, Circulation research.
[18] F. Magrini,et al. Converting-enzyme inhibition and coronary blood flow. , 1987, Circulation.
[19] G. Murray,et al. Effect of ramipril on mortality and morbidity of survivors of acute myocardial infarction with clinical evidence of heart failure. The Acute Infarction Ramipril Efficacy (AIRE) Study Investigators , 1993 .
[20] P. Anversa,et al. Myocardial response to infarction in the rat. Morphometric measurement of infarct size and myocyte cellular hypertrophy. , 1985, The American journal of pathology.
[21] P. Marino,et al. Effect of streptokinase on left ventricular modeling and function after myocardial infarction: the GISSI (Gruppo Italiano per lo Studio della Streptochinasi nell'Infarto Miocardico) Trial. , 1989, Journal of the American College of Cardiology.
[22] K. Weber,et al. Effects of endothelins on collagen turnover in cardiac fibroblasts. , 1993, Cardiovascular research.
[23] Raymond C. Schneider,et al. ISIS-4: A randomised factorial trial assessing early oral captopril, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction , 1995, The Lancet.
[24] G. Lamas,et al. Activation of neurohumoral systems in postinfarction left ventricular dysfunction. , 1993, Journal of the American College of Cardiology.
[25] V. Sukhatme,et al. Egr-1, a serum-inducible zinc finger protein, regulates transcription of the rat cardiac alpha-myosin heavy chain gene. , 1991, The Journal of biological chemistry.
[26] B. Bergman,et al. Regional differences in LV collagen accumulation and mature cross-linking after myocardial infarction in rats. , 1994, The American journal of physiology.
[27] Y. Zou,et al. Angiotensin II partly mediates mechanical stress-induced cardiac hypertrophy. , 1995, Circulation research.
[28] K. Weber,et al. Cardiac angiotensin converting enzyme and myocardial fibrosis in the rat. , 1994, Cardiovascular research.
[29] J. Covell,et al. Mechanisms of Augmented Segment Shortening in Nonischemic Areas during Acute Ischemia of the Canine Left Ventricle , 1985, Circulation research.
[30] E. J. Brown,et al. Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators. , 1992, The New England journal of medicine.
[31] D. Gardner,et al. N ATRIURETIC P EPTIDES , 1998 .
[32] G. Lamas,et al. Effect of captopril on progressive ventricular dilatation after anterior myocardial infarction. , 1988, The New England journal of medicine.
[33] G. Lamas,et al. Effect of infarct artery patency on prognosis after acute myocardial infarction. The Survival and Ventricular Enlargement Investigators. , 1995, Circulation.
[34] A. Desmoulière,et al. Transforming growth factor-beta 1 induces alpha-smooth muscle actin expression in granulation tissue myofibroblasts and in quiescent and growing cultured fibroblasts , 1993, The Journal of cell biology.
[35] K. Weber,et al. Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. , 1997, Circulation.
[36] H. White,et al. Effects of early captopril administration after thrombolysis on regional wall motion in relation to infarct artery blood flow. , 1999, Journal of the American College of Cardiology.
[37] W. Grossman,et al. Time course of left ventricular dilation after myocardial infarction: influence of infarct-related artery and success of coronary thrombolysis. , 1988, Journal of the American College of Cardiology.
[38] P. Brecher,et al. Rapid expression of fibronectin in the rabbit heart after myocardial infarction with and without reperfusion. , 1992, The Journal of clinical investigation.
[39] J. Sadoshima,et al. The heterotrimeric G q protein‐coupled angiotensin II receptor activates p21 ras via the tyrosine kinase‐Shc‐Grb2‐Sos pathway in cardiac myocytes. , 1996, The EMBO journal.
[40] J. Sadoshima,et al. Molecular characterization of the stretch-induced adaptation of cultured cardiac cells. An in vitro model of load-induced cardiac hypertrophy. , 1992, The Journal of biological chemistry.
[41] P. Sugden,et al. Depletion of mitogen-activated protein kinase using an antisense oligodeoxynucleotide approach downregulates the phenylephrine-induced hypertrophic response in rat cardiac myocytes. , 1996, Circulation research.
[42] K. Weber,et al. Angiotensin II-induced myocardial fibrosis in rats: role of nitric oxide, prostaglandins and bradykinin. , 1996, Cardiovascular research.
[43] I. Dixon,et al. Expression of Gq alpha and PLC-beta in scar and border tissue in heart failure due to myocardial infarction. , 1998, Circulation.
[44] M. Daemen,et al. Collagen remodeling after myocardial infarction in the rat heart. , 1995, The American journal of pathology.
[45] B. Jugdutt,et al. Intravenous nitroglycerin therapy to limit myocardial infarct size, expansion, and complications. Effect of timing, dosage, and infarct location. , 1988, Circulation.
[46] T. Takano,et al. [Left ventricular remodelling after acute myocardial infarction]. , 1994, Nihon rinsho. Japanese journal of clinical medicine.
[47] Gruppo Italiano per lo Studio della Soprawivenza nell'Inf Miocardico.. GISSI-3: effects of lisiriopril and transdermal glyceryl trinitrate singly and together on 6-week mortality and ventricular function after acute myocardial infarction , 1994, The Lancet.
[48] R. Doughty,et al. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease , 1997 .
[49] A. Carayon,et al. , Brigitte Angiotensin II Receptor Blockade and Role in Cardiac Fibrosis Activation of Cardiac Aldosterone Production in Rat Myocardial Infarction : Effect of , 1999 .
[50] R. Doughty,et al. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. Australia-New Zealand Heart Failure Research Collaborative Group. , 1997, Journal of the American College of Cardiology.
[51] K. Weber,et al. Regulation of collagen degradation in the rat myocardium after infarction. , 1995, Journal of molecular and cellular cardiology.
[52] J. Cleland,et al. Effect of captopril, an angiotensin-converting enzyme inhibitor, in patients with angina pectoris and heart failure. , 1991, Journal of the American College of Cardiology.
[53] J. Sadoshima,et al. Critical Role of the AT1 Receptor Subtype , 2005 .
[54] R. Jeremy,et al. Infarct artery perfusion and changes in left ventricular volume in the month after acute myocardial infarction. , 1987, Journal of the American College of Cardiology.
[55] J. Weiss,et al. Early dilation of the infarcted segment in acute transmural myocardial infarction: role of infarct expansion in acute left ventricular enlargement. , 1984, Journal of the American College of Cardiology.
[56] P. Parker,et al. Endothelin-1 and fibroblast growth factors stimulate the mitogen-activated protein kinase signaling cascade in cardiac myocytes. The potential role of the cascade in the integration of two signaling pathways leading to myocyte hypertrophy. , 1994, The Journal of biological chemistry.
[57] D. Mann,et al. Activation of matrix metalloproteinases in the failing human heart: breaking the tie that binds. , 1998, Circulation.
[58] R. Senior,et al. Beneficial effects of intravenous and oral carvedilol treatment in acute myocardial infarction. A placebo-controlled, randomized trial. , 1997, Circulation.